Bellelli E, Bracchi U, Tanzi M L, Benaglia G, Montanarini G
Eur J Epidemiol. 1986 Sep;2(3):197-204. doi: 10.1007/BF00211532.
Research on neutralizing antibodies against the 3 serotypes of poliovirus was carried out on 441 blood specimens drawn from children and young people living in Parma, a town of about 200,000 inhabitants, where the vaccination services were well organized. From June 1983 to June 1984 blood samples were taken from different groups of subjects at different stages of vaccination (before vaccination, and after 1, 2, 3, and 4 doses of trivalent balanced OPV). In addition, groups of children and young people vaccinated from 2 to more than 14 years earlier were bled. Ten per cent of unvaccinated babies (aged 1-3 months) were lacking in neutralizing antibodies for types 1 and 3 and five per cent for type 2; among children aged 4-5 months vaccinated by one dose of OPV a residual 5% of subjects without antibodies for type 1 was also found. All subjects who received two, three, or four doses, had antibodies against all serotypes of poliovirus. As for the number of administered doses, significant differences among GMTs of antibodies were recorded only for type 1, when the group given 3 doses, was compared with the group which received two and one dose, respectively. At different intervals from completion of vaccination (2-14 years), all groups we examined still had antibodies against all three serotypes. For poliovirus type 1 antibody, GMTs were not significantly different in the examined groups. For types 2 and 3 significant decreases were observed in the groups vaccinated from 2 to 5 years. The high levels of immunity observed earlier in Parma were not found throughout the entire territory.(ABSTRACT TRUNCATED AT 250 WORDS)
对从帕尔马市(一个约有20万居民的城镇,当地疫苗接种服务组织完善)的儿童和年轻人中采集的441份血液样本进行了针对脊髓灰质炎病毒3种血清型的中和抗体研究。1983年6月至1984年6月期间,在不同接种阶段(接种前、接种1剂、2剂、3剂和4剂三价口服脊髓灰质炎减毒活疫苗后)从不同组别的受试者中采集血样。此外,还对2至14年多以前接种过疫苗的儿童和年轻人组进行了采血。10%未接种疫苗的婴儿(1至3个月龄)缺乏1型和3型中和抗体,5%缺乏2型中和抗体;在接种1剂口服脊髓灰质炎减毒活疫苗的4至5个月龄儿童中,也发现仍有5%的受试者缺乏1型抗体。所有接种2剂、3剂或4剂的受试者均具有针对脊髓灰质炎病毒所有血清型的抗体。至于接种剂量,仅在1型抗体的几何平均滴度(GMT)方面,当比较接种3剂的组与分别接种2剂和1剂的组时,记录到了显著差异。在完成疫苗接种后的不同间隔时间(2至14年),我们检查的所有组仍然具有针对所有三种血清型的抗体。对于1型脊髓灰质炎病毒抗体,各检查组的GMT无显著差异。对于2型和3型,在2至5年前接种疫苗的组中观察到显著下降。帕尔马市早期观察到的高免疫水平在整个地区并未发现。(摘要截短至250字)